Trace Neuroscience Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $101M

  • Investors
  • 5

Trace Neuroscience General Information

Description

Developer of a genetic therapy designed to restore UNC13A protein function and improve communication between nerves and muscles in people with ALS. The company offers a targeted antisense oligonucleotide therapy that corrects UNC13A mRNA splicing, enabling individuals with ALS caused by TDP-43 mislocalization to improve their muscle function and extend survival potentially.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 750 Gateway Boulevard
  • Suite 200
  • San Francisco, CA 94080
  • United States
+1 (800)
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 750 Gateway Boulevard
  • Suite 200
  • San Francisco, CA 94080
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trace Neuroscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 12-Nov-2024 $101M Completed Generating Revenue
To view Trace Neuroscience’s complete valuation and funding history, request access »

Trace Neuroscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Trace Neuroscience’s complete cap table history, request access »

Trace Neuroscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trace Neuroscience Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlas Venture Venture Capital Minority
GV Corporate Venture Capital Minority
RA Capital Management Asset Manager Minority
Third Rock Ventures Venture Capital Minority
UCL Ventures University Minority
To view Trace Neuroscience’s complete investors history, request access »

Trace Neuroscience FAQs

  • When was Trace Neuroscience founded?

    Trace Neuroscience was founded in 2024.

  • Where is Trace Neuroscience headquartered?

    Trace Neuroscience is headquartered in San Francisco, CA.

  • What is the size of Trace Neuroscience?

    Trace Neuroscience has 22 total employees.

  • What industry is Trace Neuroscience in?

    Trace Neuroscience’s primary industry is Laboratory Services (Healthcare).

  • Is Trace Neuroscience a private or public company?

    Trace Neuroscience is a Private company.

  • What is the current valuation of Trace Neuroscience?

    The current valuation of Trace Neuroscience is .

  • What is Trace Neuroscience’s current revenue?

    The current revenue for Trace Neuroscience is .

  • How much funding has Trace Neuroscience raised over time?

    Trace Neuroscience has raised $101M.

  • Who are Trace Neuroscience’s investors?

    Atlas Venture, GV, RA Capital Management, Third Rock Ventures, and UCL Ventures have invested in Trace Neuroscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process